27 results
8-K
EX-99.1
AXLA
Axcella Health Inc.
1 Nov 22
Axcella Reports Third Quarter Financial Results and Provides Business Update
8:02am
EMMPACT trial in NASH.
Long COVID is a persistent and growing challenge of the pandemic, affecting an estimated one hundred million patients
424B5
albv4g041st0tnvyc4
13 Oct 22
Prospectus supplement for primary offering
7:55am
8-K
EX-99.1
funpl9 et
2 Aug 22
Axcella Announces Highly Promising Results from Phase 2a Placebo Controlled Clinical Trial for Long COVID
4:06pm
8-K
EX-99.1
wd911ktr
26 May 22
Axcella Announces Completion of Enrollment of Clinical Trial for Long COVID and Has Prioritized its Clinical Portfolio
8:12am
424B5
r4kt0
16 Mar 22
Prospectus supplement for primary offering
8:00am
8-K
EX-99.1
kxiibema pkdh050
12 Nov 20
Axcella Reports Third Quarter 2020 Financial Results and Provides Business Update
7:47am